Does Treating RA Before Symptoms Begin Delay the Disease?

Health & LifestyleNews
236

Listen to article (english)

Translate to Spanish or other 102 languages!

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. Image for illustration purposes
As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. 

While the exact cause of rheumatoid arthritis is currently unknown, scientists believe that risk is based on a number of factors, including genetics and environmental factors like smoking. 

- Advertisement -

There is also currently no way to prevent rheumatoid arthritis, especially if it runs in your family. 

Now, a study recently published in the journal has found that treating people at high risk of developing rheumatoid arthritis with a rheumatoid arthritis-specific medication may help delay disease onset for several years.

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/pretreatment-rheumatoid-arthritis-onset-delay-4-years?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-01-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New Data Shows Nursing Homes Strengthening Workforce Despite Ongoing Shortages 
Next article
DHR Health’s Free Seminar on Groundbreaking Treatment Options for Parkinson’s Disease, Feb, 28th

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -